NTU is a place where you can explore pushing back the impossible .
We are looking for people who realise the boundary can be moved and greater things achieved when we work together.
Increase the possible.
Society needs solutions to its most critical issues, such as the continuing increase in life expectancy – which we all consider to be personally fantastic, but globally that is a serious problem for us.
Tell us of a future you'd like to create and we'll give you the resources to make things happen.
That’s why we’re looking for ground-breaking, truly innovative thinkers.
We need people with new research paradigms, people who are comfortable thinking and practising right at the edge of what’s possible. You don’t have to come here with the proof that your concept or research paradigm will work.
You have to come prepared to put in time and energy into exploring your thoughts and ideas.
My role is to get us working together, forming theories, concepts and discovering new approaches, to push forward the boundary of the possible into the current space we consider to be impossible. Sometimes the ideas people have are so disruptive and so radical that if they do not push forward the boundary their ideas drop them into isolation. We are looking for people who realise this and realise the boundary can be moved and greater things achieved when we work together.
My name is John Hunt.
I’m the Strategic Research Theme Leader for Medical Technologies and Advanced Materials and the academic lead for NTU’s Medical Technologies Innovation Facility.
John’s research has focused on developing breakthrough therapies, devices and technology to repair, replace, augment and in the future regenerate diseased, infected and damaged tissues in humans and other mammals using material interventions.
Understanding the generic science to deliver interventional medical therapies requiring the use of a material (living cells are also considered a material). These will come from an in depth generic first principles approach to understanding and directing the patient’s cellular and molecular mechanisms and responses related to the clinical outcome and efficacy of medical devices, biocompatibility, inflammation and stem cell biology.
Tissue engineering processes are developed and applied, addressing the key areas of patient treatments requiring intervention and material implantation. The materials of choice being researched today also include cells and within that, expertise and intellectual property has been created relating to primary cell sourcing, controlling cell function and phenotype through defining and controlling extracellular matrix interactions, angiogenesis, inflammation, and tissue regeneration.
From a strong long lived generic research platform, specific applications and knowledge has been applied to and continue to be developed for musculoskeletal tissues specifically cartilage and bone, visceral and vascular tissues. Research has been funded by the European Commission, BBSRC, MRC and EPSRC as well as by Industry. Ph.D in 1992 and D.Sc. in 2006.
John has organised seven national and international conferences; the biggest being the European Society for Biomaterials meeting in 2014